Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Growth Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Cell Line Medicine & Life Sciences
HhAntag691 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2016

A monoclonal antibody against KCNK9 K+ channel extracellular domain inhibits tumour growth and metastasis

Sun, H., Luo, L., Lal, B., Ma, X., Chen, L., Hann, C. L., Fulton, A. M., Leahy, D. J., Laterra, J. & Li, M. Feb 4 2016 In : Nature Communications. 7, 10339

Research output: Research - peer-reviewArticle

Monoclonal Antibodies
Neoplasm Metastasis
Growth
Neoplasms
metastasis

A randomized phase II study of linsitinib (OSI-906) versus Topotecan in patients with relapsed small-cell lung cancer

Chiappori, A. A., Otterson, G. A., Dowlati, A., Traynor, A. M., Horn, L., Owonikoko, T. K., Ross, H. J., Hann, C. L., Hejleh, T. A., Nieva, J., Zhao, X., Schell, M. & Sullivan, D. M. Oct 1 2016 In : Oncologist. 21, 10, p. 1163-1164 2 p.

Research output: Research - peer-reviewArticle

Topotecan
Small Cell Lung Carcinoma
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
Confidence Intervals
Growth Factor Receptors

Small cell lung cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?

Bunn, P. A. , Minna, J. D. , Augustyn, A. , Gazdar, A. F. , Ouadah, Y. , Krasnow, M. A. , Berns, A. , Brambilla, E. , Rekhtman, N. , Massion, P. P. , Niederst, M. , Peifer, M. , Yokota, J. , Govindan, R. , Poirier, J. T. , Byers, L. A. , Wynes, M. W. , McFadden, D. G. , MacPherson, D. , Hann, C. L. & 34 others Farago, A. F., Dive, C., Teicher, B. A., Peacock, C. D., Johnson, J. E., Cobb, M. H., Wendel, H. G., Spigel, D., Sage, J., Yang, P., Pietanza, M. C., Krug, L. M., Heymach, J., Ujhazy, P., Zhou, C., Goto, K., Dowlati, A., Christensen, C. L., Park, K., Einhorn, L. H., Edelman, M. J., Giaccone, G., Gerber, D. E., Salgia, R., Owonikoko, T., Malik, S., Karachaliou, N., Gandara, D. R., Slotman, B. J., Blackhall, F., Goss, G., Thomas, R., Rudin, C. M. & Hirsch, F. R. 2016 In : Journal of Thoracic Oncology. 11, 4, p. 453-474 22 p.

Research output: Research - peer-reviewArticle

Targeted doxorubicin delivery to brain tumors via minicells: Proof of principle using dogs with spontaneously occurring tumors as a model

MacDiarmid, J. A., Langova, V., Bailey, D., Pattison, S. T., Pattison, S. L., Christensen, N., Armstrong, L. R., Brahmbhatt, V. N., Smolarczyk, K., Harrison, M. T., Costa, M., Mugridge, N. B., Sedliarou, I., Grimes, N. A., Kiss, D. L., Stillman, B., Hann, C. L., Gallia, G. L., Graham, R. M. & Brahmbhatt, H. Apr 1 2016 In : PLoS One. 11, 4, e0151832

Research output: Research - peer-reviewArticle

Brain Neoplasms
Doxorubicin
Dogs
Neoplasms
doxorubicin

Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)

Belani, C. P., Dahlberg, S. E., Rudin, C. M., Fleisher, M., Chen, H. X., Takebe, N., Velasco, M. R., Tester, W. J., Sturtz, K., Hann, C. L., Shanks, J. C., Monga, M., Ramalingam, S. S. & Schiller, J. H. 2016 (Accepted/In press) In : Cancer.

Research output: Research - peer-reviewArticle

HhAntag691
Small Cell Lung Carcinoma
Arm
Drug Therapy
Research